Indoco Remedies Limited Statistics
Want to see IN:INDOCO full AI Analyst Report?
Indoco Remedies Limited (INDOCO) Stock Statistics & Valuation Metrics
Total Valuation
Indoco Remedies Limited has a market cap or net worth of INR 20.25B. The enterprise value is INR 34.26B.
- Market Cap
- INR 20.25B
- Enterprise Value
- INR 34.26B
Share Statistics
Indoco Remedies Limited has 92,318,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 92,318,460
- Owned by Insiders
- ―
- Owned by Institutions
- 0.56%
Financial Efficiency
Indoco Remedies Limited’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is 0.69%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.04
- Return on Invested Capital (ROIC)
- 0.69%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 3.08M
- Profits Per Employee
- -164.50K
- Employee Count
- 6,000
- Asset Turnover
- 0.71
- Inventory Turnover
- 2.70
Valuation Ratios
The current PE Ratio of Indoco Remedies Limited is 64.56. Indoco Remedies Limited’s PEG ratio is 0.02.
- PE Ratio
- 64.56
- PS Ratio
- 1.07
- PB Ratio
- 1.87
- Price to FCF
- 37.45
- Price to Operating Cash Flow
- 12.12
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Indoco Remedies Limited had revenue of 18.45B and earned -987.00M in profits. Earnings per share was -10.70.
- Revenue
- 18.45B
- Gross Profit
- 7.51B
- Operating Income
- 153.50M
- Pretax Income
- -1.07B
- Net Income
- -987.00M
- EBITDA
- 1.42B
- Earnings Per Share (EPS)
- -10.70
Cash Flow
In the last 12 months, operating cash flow was 1.58B and capital expenditures -1.04B, giving a free cash flow of 540.40M billion.
- Operating Cash Flow
- 1.58B
- Free Cash Flow
- 540.40M
- Free Cash Flow per Share
- 6.20
Dividends & Yields
Indoco Remedies Limited pays an annual dividend of INR 0.20, resulting in a dividend yield of 0.09%
- Dividend Per Share
- INR 0.20
- Dividend Yield
- 0.09%
- Payout Ratio
- -3.17%
- Free Cash Flow Yield
- 2.67%
- Earnings Yield
- 1.56%
Stock Price Statistics
- Beta
- 0.89
- 52-Week Price Change
- -18.16%
- 50-Day Moving Average
- 240.88
- 200-Day Moving Average
- 221.98
- Relative Strength Index (RSI)
- 44.32
- Average Volume (3m)
- 40.00K
Important Dates
Indoco Remedies Limited upcoming earnings date is Jan 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Jan 26, 2027
- Ex-Dividend Date
- Sep 04, 2025
Financial Position
Indoco Remedies Limited as a current ratio of 1.13, with Debt / Equity ratio of 116.02%
- Current Ratio
- 1.13
- Quick Ratio
- 0.75
- Debt to Market Cap
- 0.71
- Net Debt to EBITDA
- 7.50
- Interest Coverage Ratio
- 0.13
Taxes
In the past 12 months, Indoco Remedies Limited has paid -78.10M in taxes.
- Income Tax
- -78.10M
- Effective Tax Rate
- 0.07
Enterprise Valuation
Indoco Remedies Limited EV to EBITDA ratio is 9.80, with an EV/FCF ratio of 56.40.
- EV to Sales
- 1.61
- EV to EBITDA
- 9.80
- EV to Free Cash Flow
- 56.40
- EV to Operating Cash Flow
- 19.32
Balance Sheet
Indoco Remedies Limited has INR 329.90M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 329.90M billion.
- Cash & Marketable Securities
- INR 329.90M
- Total Debt
- INR 0.00
- Net Cash
- INR 329.90M
- Net Cash Per Share
- INR 3.57
- Tangible Book Value Per Share
- INR 101.69
Margins
Gross margin is 53.58%, with operating margin of 1.86%, and net profit margin of 1.58%.
- Gross Margin
- 53.58%
- Operating Margin
- 1.86%
- Pretax Margin
- 2.41%
- Net Profit Margin
- 1.58%
- EBITDA Margin
- 16.42%
- EBIT Margin
- 9.37%
Analyst Forecast
The average price target for Indoco Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.75%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 47
